MP
Molecular Partners AG ADR
🇺🇸XNAS.MOLNUnited StatesHealthcare
$4.20USDup +0.18 (+4.48%)Pre-marketEnd of day1:29 PM
Price$4.20+0.18 (+4.48%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US60853G1067
- CUSIP
- Not reported
Company
- Employees
- 134
- Headquarters
- Schlieren, United States
- CEO
- Dr. Patrick Amstutz Ph.D.
Market
- Shares outstanding
- 38.3M
- Market cap
- $160.88M
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- $160.88M
- EPS LTM
- -CHFÂ 1.48
- P/E LTM
- -2.12
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CHFÂ 0-100%down year on year
- Net income
- -CHFÂ 57.27M+14.13%up year on year
- Gross margin
- Not reported
- Free cash flow
- -CHFÂ 51.77M+10.11%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.